Genmab A GMAB
NASDAQ GMAB
$40.00 +0.43 (+1.09%)
At close: Oct 22, 2026 · 4:00 PM EDT

Genmab A (GMAB) Treasury Shares (2025)

Updated

Genmab A (GMAB) reported Treasury Shares of 2.62 million for the quarter ended Dec 31, 2025, up 963.6% from 246,284 a year earlier.

Analysis

Genmab A (GMAB) Treasury Shares (2025) Analysis & Trends

  • By year, Treasury Shares came in at 246,284 in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn -
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 712.73 Mn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 77.11 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 1.11 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 49.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 3.94 Bn
10 Genmab A 2.57 Bn -2.81 Bn 1.07 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.62 Mn
API Access

Genmab A Treasury Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=treasury-shares&ticker=GMAB&period=max&api_key=YOUR_API_KEY